- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 31/10 - Antimycotics
Patent holdings for IPC class A61P 31/10
Total number of patents in this class: 2864
10-year publication summary
|
68
|
128
|
180
|
164
|
191
|
168
|
197
|
362
|
187
|
57
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| King Faisal University | 923 |
206 |
| Scynexis, Inc. | 66 |
23 |
| Nihon Nohyaku Co., Ltd. | 327 |
22 |
| Centre National de La Recherche Scientifique | 10870 |
20 |
| BASF SE | 21129 |
19 |
| The Board of Trustees of the University of Illinois | 2739 |
17 |
| POLA Pharma Inc. | 73 |
17 |
| Shanghai Techwell Biopharmaceutical Co., Ltd. | 63 |
16 |
| Eisai R&D Management Co., Ltd. | 1186 |
14 |
| F2g Ltd | 46 |
13 |
| Kaken Pharmaceutical Co., Ltd. | 105 |
13 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 3125 |
12 |
| University of Georgia Research Foundation, Inc. | 1060 |
11 |
| Janssen Pharmaceutica N.V. | 3235 |
10 |
| Board of Regents, The University of Texas System | 6023 |
10 |
| The Brigham and Women's Hospital, Inc. | 2258 |
10 |
| Gedea Biotech AB | 17 |
10 |
| Amtixbio Co., Ltd. | 41 |
10 |
| The Regents of the University of California | 20506 |
9 |
| The Research Foundation for The State University of New York | 1709 |
9 |
| Other owners | 2393 |